Cigna
Corporate investor
Active
Greenock, United Kingdom
8
40M
6
0.20
2
0.25
1
- Areas of investment
Summary
Cigna appeared to be the Corporate Investor, which was created in 1982. The main department of described Corporate Investor is located in the Bloomfield. The company was established in North America in United States.
The standard case for the fund is to invest in rounds with 6 partakers. Despite the Cigna, startups are often financed by U.S. Venture Partners (USVP), Designer Fund, The Vertical Group. The meaningful sponsors for the fund in investment in the same round are U.S. Venture Partners (USVP), Seven Peaks Ventures, Sanofi-Genzyme BioVentures. In the next rounds fund is usually obtained by Wellington Management, U.S. Venture Partners (USVP), Sanofi-Genzyme BioVentures.
The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Analytics, Hospital. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Omada Health, Prognos. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Considering the real fund results, this Corporate Investor is 40 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2017. The fund is constantly included in less than 2 deals per year.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 0.20
- Follow on index
- 0.25
- Investments by industry
- Health Care (5)
- Medical (4)
- Electric Vehicle (3)
- Autonomous Vehicles (3)
- Automotive (3) Show 10 more
- Investments by region
-
- Australia (3)
- United States (5)
- Peak activity year
- 2017
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 11
- Avg. valuation at time of investment
- 175M
- Group Appearance index
- 0.75
- Avg. company exit year
- 12
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ryse Health | 08 Apr 2022 | Health Care, Medical | Seed | 3M | United States, Virginia, Arlington |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.